Nova Mentis (NOVA.C) is on a mission to incorporate psychedelics in treating chronic inflammatory conditions like autism spectrum disorder (ASD), fragile X syndrome (FXS), epilepsy, traumatic brain injury, multiple…
NOVA
Nova Mentis Life Science (NOVA.C) announced they will be organising a North American autism spectrum disorder (ASD) data bank to support the development of psilocybin-based compounds in the diagnosis…
Nova Mentis Life Science (NOVA.C) announced early indications of a rescue effect through psilocybin use on anxiety-like behaviours related to autism spectrum disorder (ASD). The research involved studying…